(Reuters) - A U.S. judge has ruled that investors who claimed that Theranos Inc defrauded them into investing indirectly in the company by touting revolutionary blood-testing technology that never existed cannot pursue their claims as a class action.
from Reuters: U.S. https://ift.tt/2xERjWa
0 comments:
Post a Comment